Transgene Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.66	16.67	15.67	4.4	5.91
Short-Term Investments	105.2	-	-	22.42	43.66
Cash & Short-Term Investments	111.86	16.67	15.67	26.83	49.57
Cash Growth	571.01%	6.41%	-41.60%	-45.88%	88.09%
Accounts Receivable	3.65	1.19	0.78	2.79	10.13
Other Current Assets	2.17	2.81	1.54	16.89	2.54
Total Current Assets	117.68	20.67	17.98	46.51	62.25
Net Property, Plant & Equipment	13.5	14.29	12.31	11.18	11.3
Other Intangible Assets	0.05	0.06	0.08	0.08	0.09
Long-Term Investments	0.83	0.93	1.35	1.67	20.77
Other Long-Term Assets	6.77	6.22	13.49	7	7.43
Total Assets	138.83	42.17	45.22	66.44	101.84
Accounts Payable	6.02	9.5	4.55	6.97	7.69
Short-Term Debt	0.4	0.18	1.33	1.19	1.4
Other Current Liabilities	5.81	4.3	4.17	4.63	5.5
Total Current Liabilities	12.23	13.98	10.04	12.78	14.59
Long-Term Debt	1.66	10.22	15.96	12.33	15.24
Other Long-Term Liabilities	3.2	2.77	3.6	3.49	4.8
Total Long-Term Liabilities	4.86	12.99	19.56	15.81	20.04
Total Liabilities	17.09	26.97	29.61	28.6	34.63
Common Stock	82.26	66.15	50.43	50.1	48.89
Additional Paid-in Capital	116.67	89.23	71.59	71.62	70.37
Accumulated Other Comprehensive Income	-0.68	-0.45	-0.64	-0.45	-1.42
Retained Earnings	-76.51	-139.73	-105.76	-83.43	-50.63
Shareholders' Equity	121.74	15.2	15.61	37.84	67.21
Total Liabilities & Equity	138.83	42.17	45.22	66.44	101.84
Total Debt	2.06	10.4	17.3	13.52	16.64
Net Cash (Debt)	109.8	6.27	-1.63	13.31	32.93
Net Cash Growth	1650.06%	-	-	-59.59%	312.18%
Net Cash Per Share	0.76	0.05	-0.02	0.13	0.36
Book Value	121.74	15.2	15.61	37.84	67.21
Book Value Per Share	0.84	0.13	0.16	0.38	0.74
Tangible Book Value	121.69	15.14	15.53	37.76	67.12
Tangible Book Value Per Share	0.84	0.13	0.15	0.38	0.74